Nova Patents
IL268980B

Albumin-free botulinum toxin formulations

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

41 members in 13 offices

This recordMember, by publication datePriority claim3 more offices are in the list below

Priority claims9

Priority claims
DocumentOfficeKindDate
22043309United States of AmericaP
22043309United States of AmericaP
61220433United States of America–
2010040104United States of AmericaW
2010040104United States of AmericaW
61220433–––
PCTUS2010040104–––
US20090220433P–––
WO2010US40104–––

Members41

Family members, oldest first
DocumentOfficeKind
CA2766521A1CanadaA1
WO2010151840A2World Intellectual Property Organization (WIPO)A2
US2010330123A1United States of AmericaA1
AU2010265888A1AustraliaA1
SG177357A1SingaporeA1
IL217156A0IsraelA0
IL217156D0IsraelD0
EP2445521A2European Patent Office (EPO)A2
US2012107361A1United States of AmericaA1
MX2012000174AMexicoA
CO6491076A2ColombiaA2
KR20120102569ARepublic of KoreaA
JP2012531442AJapanA
CN102869373AChinaA
WO2010151840A3World Intellectual Property Organization (WIPO)A3
EP2445521A4European Patent Office (EPO)A4
US9340587B2United States of AmericaB2
US2016256532A1United States of AmericaA1
BRPI1015938A2BrazilA2
JP6043627B2JapanB2
MX344583BMexicoB
CN102869373BChinaB
KR101804279B1Republic of KoreaB1
KR20170133530ARepublic of KoreaA
US10111939B2United States of AmericaB2
KR101975051B1Republic of KoreaB1
KR20190047736ARepublic of KoreaA
MX366344BMexicoB
MX2019008126AMexicoA
US2019290740A1United States of AmericaA1
IL268980AIsraelA
CA2766521CCanadaC
KR102192618B1Republic of KoreaB1
KR20200141546ARepublic of KoreaA
US2021330766A1United States of AmericaA1
KR102328155B1Republic of KoreaB1
KR20210141783ARepublic of KoreaA
US11351232B2United States of AmericaB2
IL268980BThis recordIsraelB
US11911449B2United States of AmericaB2
US2024382571A1United States of AmericaA1